03/12/2025 3:27 PM | Tripuraneni Radhika (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/12/2025 3:36 PM | Tripuraneni Radhika (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 3:17 PM | CAIN CHRISTOPHER W. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/12/2025 3:19 PM | CAIN CHRISTOPHER W. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:12 PM | Harmon Seth (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:13 PM | Beetham Thomas W. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:14 PM | Mahoney Stephen F. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:17 PM | Tousignant Jennifer (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 5:09 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 424B5 | |
03/03/2025 3:35 PM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/03/2025 6:33 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VRDN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Viridian Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
02/27/2025 6:11 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 5:05 PM | Venrock Healthcare Capital Partners III, L.P. (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
12/16/2024 6:22 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:52 PM | Venrock Healthcare Capital Partners III, L.P. (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 4:53 PM | Venrock Opportunities Fund, L.P. (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 3:50 PM | PERCEPTIVE ADVISORS LLC (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 3:33 PM | Paradigm Biocapital Advisors LP (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024 6:15 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/12/2024 6:15 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024 11:33 AM | STATE STREET CORP (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13G/A | |
09/30/2024 6:12 PM | Beetham Thomas W. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 6:10 PM | Mahoney Stephen F. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 8:00 PM | Fairmount Funds Management LLC (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13D/A | |
09/17/2024 8:00 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund II GP LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 5:07 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 424B5 | |
09/12/2024 4:25 PM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/10/2024 3:28 PM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 424B5 | |
09/10/2024 6:11 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 7:25 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 7:01 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 5:31 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2024 3:25 PM | Gheuens Sarah (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 3:16 PM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 7:05 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form DEFA14A | |
05/08/2024 6:51 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 6:09 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 7:30 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 7:30 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024 7:32 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form DEFA14A | |
04/26/2024 7:32 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form DEFA14A | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before April 23rd |
04/26/2024 7:34 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form ARS | |
04/26/2024 7:34 AM | Viridian Therapeutics, Inc.\DE (Filer) Viridian Therapeutics (Filer)
| Form ARS | |
04/01/2024 5:38 PM | Fairmount Funds Management LLC (Filed by) Viridian Therapeutics, Inc.\DE (Subject) Viridian Therapeutics (Subject)
| Form SC 13D/A | |
04/01/2024 5:32 PM | Fairmount Funds Management LLC (Reporting) Fairmount Healthcare Fund GP LLC (Reporting) Fairmount Healthcare Fund II GP LLC (Reporting) Fairmount Healthcare Fund II L.P. (Reporting) Fairmount Healthcare Fund L.P. (Reporting) Viridian Therapeutics, Inc.\DE (Issuer) Viridian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |